CEL-SCI Corp. (CVM)
1.495
+0.02
(+1.01%)
USD |
NYAM |
Sep 16, 16:00
1.495
0.00 (0.00%)
After-Hours: 18:32
CEL-SCI Market Cap : 26.30M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 26.03M |
| September 14, 2026 | 26.73M |
| September 11, 2026 | 26.21M |
| September 10, 2026 | 26.73M |
| September 09, 2026 | 27.09M |
| September 08, 2026 | 29.02M |
| September 04, 2026 | 28.67M |
| September 03, 2026 | 28.32M |
| September 02, 2026 | 29.02M |
| September 01, 2026 | 28.32M |
| August 31, 2026 | 28.49M |
| August 28, 2026 | 27.44M |
| August 27, 2026 | 28.14M |
| August 26, 2026 | 28.32M |
| August 25, 2026 | 26.03M |
| August 24, 2026 | 24.27M |
| August 21, 2026 | 24.98M |
| August 20, 2026 | 25.68M |
| August 19, 2026 | 28.85M |
| August 18, 2026 | 27.97M |
| August 17, 2026 | 27.26M |
| August 14, 2026 | 27.09M |
| August 13, 2026 | 26.21M |
| August 12, 2026 | 26.03M |
| August 11, 2026 | 26.73M |
| Date | Value |
|---|---|
| August 10, 2026 | 12.65M |
| August 07, 2026 | 14.61M |
| August 06, 2026 | 13.67M |
| August 05, 2026 | 12.91M |
| August 04, 2026 | 11.55M |
| August 03, 2026 | 10.62M |
| July 31, 2026 | 9.852M |
| July 30, 2026 | 10.36M |
| July 29, 2026 | 9.682M |
| July 28, 2026 | 10.19M |
| July 27, 2026 | 10.02M |
| July 24, 2026 | 10.02M |
| July 23, 2026 | 10.11M |
| July 22, 2026 | 10.45M |
| July 21, 2026 | 10.62M |
| July 20, 2026 | 10.79M |
| July 17, 2026 | 9.937M |
| July 16, 2026 | 9.767M |
| July 15, 2026 | 9.767M |
| July 14, 2026 | 9.767M |
| July 13, 2026 | 10.36M |
| July 10, 2026 | 11.72M |
| July 09, 2026 | 11.47M |
| July 08, 2026 | 11.97M |
| July 07, 2026 | 10.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 307.26M |
| Amgen, Inc. | 203.50B |
| Anika Therapeutics, Inc. | 279.17M |
| BioCryst Pharmaceuticals, Inc. | 2.156B |
| Imunon, Inc. | 6.509M |
Market Cap Related Metrics
| Price to Book Value | 2.400 |
| Price | 1.495 |
| Earnings Yield | -172.8% |